MILLA, MONICA
 Distribuzione geografica
Continente #
EU - Europa 293
NA - Nord America 261
AS - Asia 116
AF - Africa 3
Totale 673
Nazione #
US - Stati Uniti d'America 260
RU - Federazione Russa 94
PL - Polonia 66
IE - Irlanda 45
IT - Italia 42
SG - Singapore 38
SE - Svezia 29
HK - Hong Kong 23
CN - Cina 21
IN - India 11
JO - Giordania 11
GB - Regno Unito 6
VN - Vietnam 6
CI - Costa d'Avorio 3
FI - Finlandia 3
KR - Corea 3
DE - Germania 2
FR - Francia 2
ID - Indonesia 2
AM - Armenia 1
BE - Belgio 1
CA - Canada 1
CH - Svizzera 1
HU - Ungheria 1
UA - Ucraina 1
Totale 673
Città #
Warsaw 66
Dublin 45
Chandler 35
Singapore 30
Ashburn 28
Fairfield 23
Hong Kong 14
Lawrence 13
Cambridge 12
Seattle 12
Altamura 11
Mumbai 10
Shanghai 10
Moscow 9
Buffalo 8
Houston 8
Princeton 8
Santa Clara 8
Woodbridge 8
Florence 6
Medford 6
Kent 5
Wilmington 5
Ann Arbor 4
Beijing 4
Boston 4
Dong Ket 4
New York 4
Abidjan 3
Bologna 3
London 3
Prato 3
Rome 3
San Diego 3
Seoul 3
Siano 3
Cagliari 2
Cerro al Volturno 2
Hanover 2
Helsinki 2
Norwalk 2
Paris 2
San Lazzaro di Savena 2
Boardman 1
Brussels 1
Genoa 1
Hillsboro 1
Islington 1
New Bedfont 1
Pune 1
Radicondoli 1
Redwood City 1
Sopron 1
Stirling 1
Toronto 1
Yerevan 1
Totale 451
Nome #
Stevens-Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease 105
Thrombosis in inflammatory bowel diseases: What's the link? 101
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease 87
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 54
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 51
Clinical characteristics of psoriasis in inflammatory bowel disease patients 49
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 49
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry 45
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey 43
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study 39
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease 35
Correlation of Ultrasound Scores with Endoscopic Activity in Crohn's Disease: A Prospective Exploratory Study 16
Applicability of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to ulcerative colitis: a preliminary study 13
Totale 687
Categoria #
all - tutte 3.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023 0 0 0 2 2 2 2 2 2 1 10 0
2020/202199 6 10 2 17 6 10 6 9 9 14 3 7
2021/202255 2 2 2 0 1 5 4 2 5 7 13 12
2022/2023202 12 39 10 8 16 38 27 10 27 3 10 2
2023/2024121 2 10 14 4 6 13 15 31 6 6 11 3
2024/2025169 35 86 48 0 0 0 0 0 0 0 0 0
Totale 687